oral cancer

FDA fast-tracks Lymphoseek for HNC detection

The U.S. Food and Drug Administration (FDA) has granted fast-track designation to Navidea Biopharmaceuticals’ Lymphoseek (technetium-99m tilmanocept) injection for sentinel lymph node detection in head

New biomarker for oral cancer found

Canadian researchers have identified a protein that can help predict whether a patient will develop oral cancer, according to a recent study in the International

WhatsApp